CMC Forum - BioProcess International

Feedback Advertise Submit Papers Reprints About Help Contact

Advanced Search

Follow BPI on Twitter

Upstream Processing Downstream Processing Manufacturing Analytical Facilities

Archive by Issue Archive by Article Type Supplements

CMC Forum Press Releases

CMC Forum

The Roles of Bioactivity Assays in Lot Release and Stability Testing

BioProcess International, Vol. 8, No. 6, June 2010, pp. 33–42

Practical Applications of Quality Risk Management

BioProcess International, Vol. 8, No. 3, March 2010, pp. 20–32

Raw Material Control Strategies for Bioprocesses

BioProcess International, Vol. 7, No. 8, September 2009, pp. 18–33

Quality by Design: The Next Phase

BioProcess International, Vol. 7, No. 1, January 2009, pp. 34–42

Demonstrating Comparability for Well-Characterized Biotechnology Products

BioProcess International, Vol. 6, No. 2, February 2008, pp. 32–43

Lot Release and Characterization Testing of Live-Virus-Based Vaccines and Gene Therapy Products, Part 2

BioProcess International, Vol. 4, No. 5, May 2006, pp. 56-65

Lot Release and Characterization Testing of Live-Virus-Based Vaccines and Gene Therapy Products, Part 1

BioProcess International, Vol. 4, No. 4, April 2006, pp. 46-54

Defining Your Product Profile and Maintaining Control Over It, Part 4

BioProcess International, Vol. 3, No. 10, November 2005, pp. 50-54

Defining Your Product Profile and Maintaining Control Over It, Part 3

BioProcess International, Vol. 3, No. 9, October 2005, pp. 50-56

Defining Your Product Profile and Maintaining Control Over It, Part 2

BioProcess International, Vol. 3, No. 8, September 2005, pp. 52-57

Defining Your Product Profile and Maintaining Control Over It, Part 1

BioProcess International, Vol. 3, No. 6, June 2005, pp. 32–40

What Is Test Method Qualification?

BioProcess International, Vol. 2, No. 8, September 2004, pp. 32–46

Biopharmaceutical Production
Facility Design Strategies for Single-Use Technologies

Please join us for a free webinar addressing strategies for facility design in biopharmaceutical manufacturing:

Wednesday, 29 February 2012
8:00 AM and 1:00 PM EST

Presented by:

Ingrid Long, MSc
Research Engineer
GE Healthcare Life Sciences

During the webinar, Ms. Long will discuss the impact of different strategies for facility design, with a focus on the following topics:

* Replacement of traditional equipment with the single-use equivalent
* Biopharmaceutical manufacturing in a single room
* Benefits of facility design with respect to cost, risk, and flexibility

Editors' Blog

Biopharmaceutical Development and Production Week

Nine Conferences — One Location: Hilton Bayfront (San Diego, CA)

Current Issue